New hope for brain tumor patients: targeted radiation shows promise
NCT ID NCT03971461
First seen Mar 27, 2026 · Last updated Jun 06, 2026 · Updated 10 times
Summary
This study tests a drug called Lutathera, which delivers radiation directly to tumor cells, in 32 adults with a type of brain tumor called meningioma that is growing or hard to treat. Participants receive four doses of the drug through an IV, 8 weeks apart. The main goal is to see if the tumor stops growing or shrinks after 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
NYU Langone Health
New York, New York, 10016, United States
Conditions
Explore the condition pages connected to this study.